mexiletine has been researched along with Palsy in 2 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
Excerpt | Relevance | Reference |
---|---|---|
"A 27-year-old woman presented with paramyotonia congenita since her childhood." | 1.40 | Focal and abnormally persistent paralysis associated with congenital paramyotonia. ( David, A; Magot, A; Péréon, Y; Sternberg, D, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Magot, A | 1 |
David, A | 1 |
Sternberg, D | 1 |
Péréon, Y | 1 |
Mohammadi, B | 1 |
Jurkat-Rott, K | 1 |
Alekov, A | 1 |
Dengler, R | 1 |
Bufler, J | 1 |
Lehmann-Horn, F | 1 |
2 other studies available for mexiletine and Palsy
Article | Year |
---|---|
Focal and abnormally persistent paralysis associated with congenital paramyotonia.
Topics: Female; Humans; Mexiletine; Mutation; Myotonia Congenita; NAV1.4 Voltage-Gated Sodium Channel; Paral | 2014 |
Preferred mexiletine block of human sodium channels with IVS4 mutations and its pH-dependence.
Topics: Anti-Arrhythmia Agents; Cell Line; Cysteine; Exercise; Histidine; Humans; Hydrogen-Ion Concentration | 2005 |